Table 1.
Summary of patient and tumor characteristics.
| Characteristics | Value |
|---|---|
| Number of patients (N) | 10 |
| Tumor characteristics | |
| Number of unique tumors (N) | 10 |
| Longest diameter by MRI (cm) [median (interquartile range)] | 3.4 (2.3–5.6) |
| Stage II (N) | 6 |
| Stage III (N) | 4 |
| Age (years) [median (interquartile range)] | 46.5 (39.3–57.8) |
| Body weight (kg) [median (interquartile range)] | 66.6 (63.0–68.2) |
| Menopause status (N) | |
| Pre-menopause (< 50 years) | 6 |
| Post-menopause (> 50 years) | 4 |
| Subtypes (N) | |
| ER+/PR+/HER2+ | 2 |
| ER+/PR+/HER2− | 4 |
| ER−/PR−/HER2+ | 1 |
| ER−/PR−/HER2− | 3 |
| Nodal status | |
| Number of positive nodes (N) | 15 |
| Patients with positive involvement (%) | 80% |
| Patients without positive involvement (%) | 20% |
ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor-2, MRI magnetic resonance imaging.